Compounds > ondansetron

ondansetron and metopimazine

ondansetron has been researched along with metopimazine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballatori, E; Del Favero, A; Roila, F1
Boesgaard, M; Dombernowsky, P; Herrstedt, J; Jensen, TP; Sigsgaard, T1
Dombernowsky, P; Handberg, J; Hansen, M; Herrstedt, J; Schousboe, BM; Sigsgaard, T1
Saphir, A1
d'Allens, H; Depierre, A; Giovannini, M; Hédouin, M; Kaluzinski, L; Lebeau, B; Rivière, A; Votan, B1
Dombernowsky, P; Handberg, J; Herrstedt, J; Kjaer, M; Sigsgaard, T1
Bartels, U; Dupuis, LL; Feldman, BM; Greenberg, ML; Nathan, PC; Ota, S; Tomlinson, G1
Bloch, J; Delgado, A; Khayat, D; Meric, JB; Rixe, O1
Bensaoula, O; Bethune-Volters, A; Chidiac, J; Delgado, A; Di Palma, M; Khamales, S1

Trials

7 trial(s) available for ondansetron and metopimazine

ArticleYear
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.
    The New England journal of medicine, 1993, Apr-15, Volume: 328, Issue:15

    Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Ondansetron; Vomiting

1993
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Severity of Illness Index; Treatment Outcome; Vomiting

1997
The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:9

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Humans; Isonipecotic Acids; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Ondansetron; Prognosis; Quality of Life; Vomiting

1997
Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isonipecotic Acids; Logistic Models; Middle Aged; Nausea; Ondansetron; Prednisolone; Statistics, Nonparametric; Vomiting

2001
A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Bayes Theorem; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isonipecotic Acids; Male; Nausea; Ondansetron; Ontario; Pilot Projects; Treatment Outcome; Vomiting

2006
Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Current medical research and opinion, 2005, Volume: 21, Issue:11

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Ondansetron; Quality of Life; Surveys and Questionnaires; Vomiting

2005
A randomized, double-blind trial assessing the efficacy and safety of sublingual metopimazine and ondansetron in the prophylaxis of chemotherapy-induced delayed emesis.
    Anti-cancer drugs, 2006, Volume: 17, Issue:2

    Topics: Administration, Sublingual; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Ondansetron; Quality of Life; Surveys and Questionnaires; Vomiting

2006

Other Studies

2 other study(ies) available for ondansetron and metopimazine

ArticleYear
Antiemetic effects of ondansetron and metopimazine.
    The New England journal of medicine, 1993, Oct-28, Volume: 329, Issue:18

    Topics: Antiemetics; Drug Therapy, Combination; Humans; Isonipecotic Acids; Nausea; Ondansetron; Vomiting

1993
Fighting nausea in the '90s: more and better anti-emetics can help.
    Journal of the National Cancer Institute, 1997, Sep-03, Volume: 89, Issue:17

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting

1997